University Hospital Tübingen, Center for Neurology
Tübingen, 72076, Germany
NCT Number: NCT03104088
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Tübingen, 72076, Germany
Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTAB® and MoCA.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)
Montreal cognitive assessment (MOCA) in German
Time frame: day 1
Number of SPG4 patients with affections in the examined cognitive domains by using CANTAB
University Hospital Tuebingen
Other
Studying Cognition in SPG4 Compared to Healthy Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07711834
Cognition Disorders, Cognitive Dysfunction
Harbin, Heilongjiang, China
View Trial DetailsNCT07396779
Behavior, Behavioral Symptoms
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT03121209
Arterial Occlusive Diseases, Brain Diseases
Birmingham, Alabama, United States
View Trial Details